The emergence of the increasingly sophisticated tests and treatments underpinning personalized medicine raises new questions about how to regulate, pay for, and integrate these tools into health systems whose capacity is already stretched by existing one-size-fits-all interventions. To guide health systems and policymakers toward personalized medicine, we must put in place public policies that pave the way for this new era.

It is in this context that I am pleased to share PMC’s 2024 Policy Agenda, which complements the Coalition’s Strategic Plan and Research Program.

The Coalition’s 2024 policy agenda is more robust than ever. It prioritizes 16 issues identified by PMC members as critically important for the advancement of personalized medicine. It also calls for close monitoring of 17 additional issues that PMC may need to engage this year.

Following multiple rounds of feedback from members over several months, the policy agenda identifies opportunities to help modernize regulatory, coverage, and payment policies; cultivate governmental support for initiatives that will advance personalized medicine; and encourage new innovations in care delivery and value assessment that will support the field’s continued progress. The agenda lights the way toward the brighter future we can build for patients and health systems with a continued focus on targeting the right treatments to the right patients at the right times.

We appreciate the comments PMC members shared through the open-ended discussion questions, our issue prioritization survey, and through our working group and committee calls to help us develop the agenda.

If you or your institution would like more information about the many ways you can contribute to PMC’s advocacy work, please do not hesitate to contact me at cbens@personalizedmedicinecoalition.org.